posted byUrudinachi Blessing
April 3, 2025

MAUREEN OKAM-ACHEBE WINS 2024 FACULTY AWARD AT HARVARD’S BRIGHAM AND WOMEN’S HOSPITAL.

share

MAUREEN OKAM-ACHEBE WINS 2024 FACULTY AWARD AT HARVARD’S BRIGHAM AND WOMEN’S HOSPITAL.

MAUREEN OKAM-ACHEBE WINS 2024 FACULTY AWARD AT HARVARD’S BRIGHAM AND WOMEN’S HOSPITAL.

Maureen Okam-Achebe, daughter of the renowned novelist Chinua Achebe, has been honored with the 2024 Faculty Development and Diversity Award by Brigham and Women's Hospital of Harvard Medical School. This prestigious award recognizes her outstanding contributions and commitment to diversity in the medical field. Maureen's achievements reflect her dedication to advancing medical education and healthcare.



Maureen Okam-Achebe holds multiple prestigious roles, including President of AIDE Healthcare International, Associate Professor at Harvard Medical School, Director of the Outpatient Infusion Centre at Brigham and Women's Hospital, Clinical Director of the Non-Malignant Hematology Clinic, and Director of the Sickle Cell Programme at Brigham and Women's Hospital. She is also an Instructor in Medicine at Harvard Medical School and is triple-board certified in Medical Oncology, Hematology, and Internal Medicine.



Maureen Achebe earned her first medical degree from the University of Port Harcourt, Nigeria; a Haematology and Medical Oncology training at Yale School of Medicine; and a Master's in Public Health at Harvard's T.H. Chan School of Public Health. The doctor co-chairs the data subcommittee of the American Society of Hematology Consortium on Newborn Screening for Sickle Cell Disease in Africa and serves as a commissioner on the Lancet Non-Communicable Disease and Injuries Nigeria Poverty Commission as the sickle cell disease expert.



The Brigham and Women's Hospital 2024 Faculty Development and Diversity Award is a testament to Maureen's exceptional contributions across clinical care, research, education, and community service. Her work focuses on identifying and prioritizing policies and interventions to reduce the burden of SCD in Nigeria. Dr. Achebe is actively involved in clinical trials and translational research at Brigham and Women's Hospital and has been an investigator in the development of two recently approved US FDA drugs for SCD.



In conclusion, Maureen Okam-Achebe's recognition with the 2024 Faculty Development and Diversity Award by Brigham and Women's Hospital of Harvard Medical School is a well-deserved acknowledgment of her outstanding contributions to the medical field. Her dedication to advancing medical education and healthcare, particularly in the area of sickle cell disease, is truly commendable. This award serves as an inspiration to many, and her work will undoubtedly have a lasting impact on the lives of countless individuals.

Powered by Froala Editor